See also separate entry for ceftazidime.
- TRADE NAME: Avycaz (Cerexa)
- INDICATIONS: Various infections caused by susceptible organisms
- CLASS: Antibiotic, Antibiotic; beta-lactam (avibactam), Antimicrobial, Cephalosporin, Cephalosporin; 3rd generation (ceftazidime)
- HALF-LIFE: <3 hours
- FDA APPROVAL DATE: 02/25/2015
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Probenecid
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/07/2024
